Clearside Biomedical

Developer of drug therapies to treat chronic, blinding diseases of the eye

placeAlpharetta, Georgia, United States calendar_todayFounded 2011 groups30 employees language clearsidebio.com

Registered entities

Social engagement

Social engagement: 3.4K social following, 4 posts in the last 12 months — top quartile of its industry.

Investor mix

12 investors on record; lead investors include Perceptive Advisors, Rock Springs Capital, Aju IB Investment, Hatteras Venture Partners.

Investor typeCountShare
Venture capital975%
Private equity18%
Accelerator & incubator18%
Other / undisclosed18%

Recent activity

26 Aug 2025
Event
25th European Society of Retina Specialists (EURETINA) Congress
23 Jul 2025
Product launch
XIPERE® Surachoroidal Treatment for Uveitic Macular Edema
17 Jul 2025
Partnership
ClearsideBio
Coming soon